After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Scivita Medical Expands Collaboration with Boston Scientific.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Boston Scientific Corp. is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Boston Scientific Corp. is $100.67B. A total of 4.07 million shares were traded on the day, compared to an average of 6.56M shares.
In the most recent transaction, Mirviss Jeffrey B. sold 14,506 shares of BSX for 66.45 per share on Mar 18 ’24. After the transaction, the EVP&Pres, Periph Intervent now owns 58,098 company shares. In a previous transaction on Mar 01 ’24, Carruthers Wendy sold 6,983 shares at 66.35 per share. BSX shares that EVP, Human Resources owns now total 53,788.
Among the insiders who sold shares, Butcher Arthur C disposed of 9,335 shares on Feb 26 ’24 at a per-share price of $67.07. This resulted in the EVP& Grp Pres, MedSurg & APAC holding 28,937 shares of BSX after the transaction. In another insider transaction, Carruthers Wendy sold 6,983 shares at $66.89 per share on Feb 23 ’24. Company shares held by the EVP, Human Resources now total 56,508.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, BSX has a high of $68.12 and a low of $48.10.
As of this writing, BSX has an earnings estimate of $0.51 per share for the current quarter. EPS was calculated based on a consensus of 25 estimates, with a high estimate of $0.52 per share and a lower estimate of $0.49. The company reported an EPS of $0.5 in the last quarter, which was 4.20% higher than expectations of $0.48.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BSX’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $9.45B in debt and $4.27B in liabilities at the time. Its Book Value Per Share was $13.16, while its Total Shareholder’s Equity was $16.62B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BSX is Buy with a score of 4.70.
